Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON21847
NL-OMON21847
Not yet recruiting
Not Applicable

Pharmacogenetics Use For Further treatment Improvement in childre

Academic Medical Center (AMC)0 sites310 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsncontrolled asthma, LABA response heterogeneity<br /><br />Ongecontroleerd astma, LABA respons heterogeniteit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ncontrolled asthma, LABA response heterogeneity<br /><br />Ongecontroleerd astma, LABA respons heterogeniteit
Sponsor
Academic Medical Center (AMC)
Enrollment
310
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Vijverberg SJ, Pijnenburg MW, Hövels AM, Koppelman GH, Maitland-van der Zee AH. The need for precision medicine clinical trials in childhood asthma: rationale and design of the PUFFIN trial. Pharmacogenomics. 2017;18(4):393-401.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Academic Medical Center (AMC)

Eligibility Criteria

Inclusion Criteria

  • •Between 6\-18 years of age
  • •\- Doctor's diagnosis of asthma based on FEV1 reversibility \>\= 12% ever and/or bronchial hyperresponsiveness ever

Exclusion Criteria

  • •\- Active smoking
  • •\- Congenital heart disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Genotype-guided treatment of children with uncontrolled asthmaChildren with persistent uncontrolled asthmaTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
EUCTR2017-004424-29-NLAcademic Medical Center25
Active, not recruiting
Not Applicable
APPLICATION OF PHARMACOGENOMICS IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER - PHARMACOGENOMICS IN THE ELDERLYELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCERMedDRA version: 6.1Level: HLTClassification code 10010040
EUCTR2006-004016-40-ITAZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI
Recruiting
Phase 1
Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular CarcinomaHCCHepatocellular Carcinoma
NCT06527495Assiut University150
Not yet recruiting
Not Applicable
Clinical utility of genetic testing based treatment of depression in India as per recommendations of international guidelines
CTRI/2022/08/044982Indian Council of Medical Research
Completed
Not Applicable
Pharmacogenetics Use For Further Treatment Improvement in childreNAsthma in Children
NCT03654508Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)102